- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 19/08 - Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Patent holdings for IPC class A61P 19/08
Total number of patents in this class: 2108
10-year publication summary
|
63
|
111
|
134
|
138
|
136
|
153
|
165
|
156
|
141
|
120
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Société des Produits Nestlé S.A. | 10044 |
40 |
| The Regents of the University of California | 20902 |
27 |
| Alexion Pharmaceuticals, Inc. | 649 |
26 |
| Daiichi Sankyo Company, Limited | 1890 |
23 |
| Ascendis Pharma Growth Disorders A/S | 62 |
22 |
| Takeda Pharmaceutical Company Limited | 2700 |
20 |
| BioMarin Pharmaceutical Inc. | 399 |
20 |
| Novartis AG | 10169 |
19 |
| Genzyme Corporation | 1381 |
16 |
| Keros Therapeutics, Inc. | 82 |
13 |
| Amgen Inc. | 4467 |
12 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3324 |
11 |
| Megmilk Snow Brand Co., Ltd. | 206 |
11 |
| Carna Biosciences, Inc. | 67 |
10 |
| Osaka University | 3257 |
10 |
| University of Massachusetts | 2341 |
10 |
| Nestec S.A. | 2540 |
9 |
| Acceleron Pharma Inc. | 339 |
9 |
| Kyoto University | 2934 |
9 |
| Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences | 2168 |
9 |
| Other owners | 1782 |